Page last updated: 2024-10-29

ketoconazole and Virus Diseases

ketoconazole has been researched along with Virus Diseases in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Virus Diseases: A general term for diseases caused by viruses.

Research Excerpts

ExcerptRelevanceReference
"Levocabastine nasal spray was administered as two sprays per nostril (0."2.69Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastine. ( Grover, M; Hall, N; Hassell, A; Hunt, T; Lee, P; Mechlinski, W; Pesco-Koplowitz, L; Smith, R; Travers, S; Wiesinger, B; Zhou, H, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pesco-Koplowitz, L1
Hassell, A1
Lee, P1
Zhou, H1
Hall, N1
Wiesinger, B1
Mechlinski, W1
Grover, M1
Hunt, T1
Smith, R1
Travers, S1

Trials

1 trial available for ketoconazole and Virus Diseases

ArticleYear
Lack of effect of erythromycin and ketoconazole on the pharmacokinetics and pharmacodynamics of steady-state intranasal levocabastine.
    Journal of clinical pharmacology, 1999, Volume: 39, Issue:1

    Topics: Administration, Intranasal; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Area Un

1999